Sansure Biotech Inc.’s Net Profit Rose 0.4% in First Half of 2022

Sansure Biotech Inc. (圣湘生物科技股份有限公司) (688289.SH) reported a net profit of 1.1 billion yuan in the first half of 2022, up 0.4% year-on-year.

Meanwhile, the company posted 2.7 billion yuan in revenue, up 32.6% year-on-year.

At the end of the reporting period, it had 8.1 billion yuan in total assets and 900.2 million yuan in total liabilities, with a liability-to-asset ratio of 11.1%.